Introduction {#sec1}
============

Air pollution, especially that of developing countries, has become increasingly severe with the process of industrialization. Even before atmospheric brown cloud (ABC) was first observed in Asia, ambient particulate matter (PM) has been widely regarded as one of the major airborne pollutants. PM is composed of solids and/or liquids suspended in the atmosphere with a large variation in size. PM can be classified into four different categories according to aerodynamic diameters: total suspended particulates (TSPs); inhalable particles with an aerodynamic diameter less than 10 μm (PM~10~); fine PM with an aerodynamic diameter less than 2.5 μm (PM~2.5~); and ultrafine particles (PM~0.1~). Owing to the relatively high dispersity and small diameter, PM~2.5~ can be inhaled and deposited in airways and alveoli and can even penetrate into the bloodstream, systemically spreading and inducing damage to multiple systems and organs ([@ref178]; [@ref36]; [@ref106]). PM~2.5~ is derived from industrial and vehicle emissions, mineral dust, biomass incineration, and other diverse sources; thus, the composition of PM~2.5~ is extremely complex ([@ref5]; [@ref36]). Transitional metals, soluble salts, organic/elemental carbon, and microbes that adhere to PM~2.5~ particles contribute to the toxic effects of PM~2.5~ including inflammation, DNA damage, mutations, reactive oxygen species (ROS) accumulation, and mitochondria dysfunction. All these abnormal intracellular events are highly correlated with the pathogenesis and progression of a series of human diseases ([@ref45]; [@ref168]; [@ref37]; [@ref127]). Outdoor PM~2.5~ exposure has been listed as the fifth most influential risk factor for global death, which caused 4.2 million deaths in 2015 ([@ref143]). Besides, epidemiological studies have shown that PM~2.5~ exposure was highly correlated with the morbidity and mortality of respiratory and cardiovascular diseases. Maternal exposure to PM~2.5~ is also linked to an increased risk of airway disease development in offspring ([@ref135]; [@ref139]).

Epithelial-mesenchymal transition (EMT) is a process through which epithelial cells lose their apical-basal polarity and acquire the mesenchymal phenotype ([@ref79]; [@ref11]). A series of underlying molecular events, especially the repression of E-cadherin expression, the upregulation of N-cadherin and vimentin, and the disruption of adherin junctions, have been uncovered ([@ref84]; [@ref118]). Other significant molecular features underlying EMT include cytoskeleton remodeling, such as actin stress fiber formation, and induction of mesenchymal biomarkers, including α-smooth muscle actin (α-SMA) and fibronectin ([@ref78]). As EMT endows the epithelia with the potential of myofibroblast differentiation, increased motility, migration and invasion ability, this cellular event, if abnormally activated, will inevitably mediate the progression of organ fibrosis and cancer metastasis by facilitating the secretion of the extracellular matrix components or the dissociation of neoplastic cells from primary tumors and the subsequent intravasation ([@ref154]; [@ref191]; [@ref108]). Furthermore, the enhanced anti-apoptosis and drug detoxification characteristics of cancer cells that have undergone EMT also result in drug resistance in cancer chemotherapy ([@ref137]).

To date, three EMT subtypes have been determined based on their biological functions in tissue development and pathogenesis. Type 1 EMT is associated with the formation and implantation of embryo together with organ development. Type 2 EMT functions in wound healing by contributing to fibroblast generation and extracellular matrix production. Type 3 EMT refers to the phenotypic transformation in neoplastic epithelial cells, which enhances anti-apoptosis and invasion abilities ([@ref77]; [@ref78]; [@ref210]).

Although massive statistical analyses have established the causal link between environmental PM~2.5~ exposure and morbidity/mortality of multiple cancers as well as fibrotic diseases, and "outdoor air pollution, particulate matter in" has been indexed as one of 120 primary carcinogens, the exact in-depth mechanisms at the cellular or microscopic level are still largely unknown ([@ref80]; [@ref144]; [@ref15]; [@ref65]). As these diseases are currently largely irreversible and lethal, targeted approaches to prevent their onset should be developed. Current research has demonstrated that acute or chronic PM~2.5~ exposure elicited the expression of characteristic EMT markers and EMT-related transcription factors (TFs) in the epithelia ([@ref180]; [@ref16]; [@ref185]). Similar altered expression patterns have also been detected in the lungs after mice were exposed to PM~2.5~ ([@ref42]). Hence, it is possible that PM~2.5~ might serve as an exogenous promoter of fibrosis and cancer by initiating abnormal EMT in corresponding target epithelial tissues and cells. Although the molecular toxicology of PM~2.5~-induced EMT has not been well studied, on the basis of existing publications, this review aims to describe validated or potential molecular processes, especially the signaling pathways, participating in the action of PM~2.5~ on pro-fibrotic or neoplastic EMT.

Overview of the Molecular Players in Epithelial-Mesenchymal Transition {#sec2}
======================================================================

Key Transcription Factors {#sec3}
-------------------------

The loss of E-cadherin is a typical EMT hallmark. The TFs that control the expression of E-cadherin include the Zn-finger proteins Snail and Slug, the two-handed Zn-finger proteins ZEB1 and ZEB2, and the basic helix-loop-helix family protein TCF and Twist have also been identified ([@ref51]; [@ref7]). These TFs directly bind to 5′ E-boxes of the human E-cadherin promoter and further silence the transcription of CDH1 ([@ref4]; [@ref51]; [@ref171]). Lymphoid enhancer-binding factor-1 (LEF-1), a member of TCF/LEF family, also regulates EMT by recruiting the coactivator β-catenin to enhancers ([@ref46]; [@ref138]). Interactions and crosstalk between TFs have also been extensively recognized. Snail can induce the expression of ZEB1/2, Twist, Slug, and LEF-1 ([@ref51]; [@ref25]; [@ref10]). Twist can serve as the transcriptional initiator of Slug and ZEB1, whereas TCF-4 functions indirectly *via* ZEB1 ([@ref160]; [@ref136]). LEF-1 can also exert its pro-EMT ability indirectly by upregulating Slug expression ([@ref86]). In addition, a member of the high-mobility group (HMG) protein family, the transforming growth factor β (TGF-β)/SMAD2/3-dependent TF HMGA2, induces the expression of Snail, Slug, and Twist and mediates EMT ([@ref165], [@ref164]). NF-κB, a versatile TF involved in the regulation of proliferation, adhesion, and inflammation, executes its pro-EMT ability *via* Snail, Slug, and ZEB1/2 ([@ref116]; [@ref140]; [@ref161]). Key TFs related to EMT and their transcriptional interactions are roughly summarized in [Table 1](#tab1){ref-type="table"}.

###### 

Positive transcriptional regulation among pro-EMT transcription factors.

  Transcriptional inducers   Effectors   Reference
  -------------------------- ----------- -----------
  Snail                      Slug        [@ref10]
  Twist                      [@ref10]    
  ZEB1                       [@ref25]    
  ZEB2                       [@ref10]    
  LEF-1                      [@ref51]    
  LEF-1                      Slug        [@ref86]
  Twist                      Slug        [@ref160]
  ZEB1                       [@ref160]   
  TCF-4                      ZEB1        [@ref136]
  HMGA2                      Snail       [@ref164]
  Slug                       [@ref165]   
  Twist                      [@ref165]   
  NF-κB                      Snail       [@ref140]
  Slug                       [@ref155]   
  ZEB1                       [@ref116]   
  ZEB2                       [@ref116]   

*EMT, epithelial-mesenchymal transition*.

Pro-Epithelial-Mesenchymal Transition Signaling Cascades {#sec4}
--------------------------------------------------------

TGF-β is considered as the most powerful initiator of EMT. TGF-β can directly and positively regulate mesenchymal markers such as α-SMA and type I collagen (COL1) and is also a potent regulator of cytoskeleton remodeling ([@ref199]; [@ref38]). The type II TGF-β receptor (TβRII) is initially recruited by activated TGF-β and forms a hetero-tetrameric complex with the type I TGF-β receptor (TβRI) by phosphorylating the GS domain of TβRI ([@ref117]; [@ref60]; [@ref169]). SMAD2 and SMAD3, receptor-activated SMAD proteins (R-SMADs), are cytoplasmic mediators of TGF-β signaling whose recruitment and phosphorylation by TβRI result in their translocation to the nucleus in assistance of SMAD4 ([@ref35]). SMAD2/3/4 together with other coactivators activates HMGA2, Snail, Slug, and ZEB1/2 expression, which further initiates the phenotypic transformation of EMT ([@ref165]; [@ref79]). Another set of SMAD signaling cascades consisting of bone morphogenetic protein receptors (BMPRs) and the SMAD 1/5/8 also enhances Slug and Twist expression ([@ref112]; [@ref99]; [@ref1]; [@ref175]). SMAD6 and SMAD7, two inhibitory SMADs (I-SMADs), participate in the inhibition of signal transduction *via* competitive binding with TβRI and BMPRI ([@ref68]; [@ref48]; [@ref82]). There are also non-canonical TGF-β cascades linked with EMT, in which TβRII phosphorylates Par6 and further modulates activity of RhoA *via* ubiquitination mediated by Smurf1, resulting in the loss of tight junction and EMT ([@ref18]; [@ref150]).

β-Catenin is the main effector of Wnt pathway. The cytoplasmic accumulation of β-catenin after activation of Wnt signaling, or the release of β-catenin due to the loss of E-cadherin, which allow the interactions between β-catenin and LEF-1, can induce the upregulation of Snail, Slug, Twist and mesenchymal markers such as fibronectin ([@ref55]; [@ref44]). When the Wnt ligands bind to Frizzle and LDL receptor-related protein-5/6 (LRP5/6) receptors, extracellular signals are transduced by LRP to phosphorylated Disheveled (Dsh), which in turn block the activity of glycogen synthase kinase-3β (GSK-3β), a key EMT suppressor that mediates the ubiquitination of Snail and the degradative phosphorylation of β-catenin ([@ref31]; [@ref58]; [@ref85]; [@ref47]).

The receptor tyrosine kinases (RTKs) and their downstream effectors are also pivotal in EMT. There are numerous growth factors (GFs), including epidermal GF (EGF), fibroblast GF (FGF), platelet-derived GF (PDGF), and insulin-like GF (IGF), which serve as RTK ligands ([@ref71]; [@ref10]; [@ref147]; [@ref189]). Binding of GFs with RTKs and the ensuing tyrosine autophosphorylation of RTKs can result in binding of GTP to Ras and the recruitment of Raf, activating mitogen-activated protein kinase (MAPK)/extracellular signal-regulated protein kinase (ERK) kinase (MEK), which further phosphorylates ERKs. Ligand-bound RTKs also activate phosphoinositide 3-kinase (PI3K), which activates Akt *via* PIP~3~ converted from PIP~2~. Activation of Akt and ERK leads to the inactivating phosphorylation of GSK-3β, which promotes EMT ([@ref123]; [@ref208]; [@ref29]; [@ref31]; [@ref93]; [@ref167]). Akt activation also contributes to signal transduction through the NF-κB/Snail pathway ([@ref76]).

The Janus kinase/signal transducers and activators of transcription-3 (JAK/STAT3) pathway, which were initially defined as the inflammation response-related pathway, also actively participate in EMT. Interleukin-6 (IL-6) activates JAK after binding to IL-6 receptor, which subsequently facilitates the phosphorylation and the following dimerization of STAT3. STAT3 homodimer then translocates into the nucleus and regulate the transcription ([@ref191]). The IL-6/JAK/STAT3 pathway can effectively upregulate pro-EMT TFs, including Snail, Slug, and Twist and modify the expression of EMT-related genes ([@ref21]; [@ref156]; [@ref188]; [@ref14]). In addition, interleukin-8 (IL-8) can also induce similar JAK/STAT3-dependent responses through interactions with IL-8 receptor ([@ref39]; [@ref41]).

The sonic hedgehog (Shh) signaling pathway consisting of Shh, protein patch homolog (PTCH), smoothend (SMO), and glima-associated oncogene-1/2/3 (Gli1/2/3) mediates embryonic development. Recently, the importance of this pathway in cancer and EMT has also been revealed ([@ref113]; [@ref210]). Upon binding to the transmembrane G protein-coupled receptor PTCH, secretive Shh releases the repressed SMO-bound PTCH, which further induces the transcriptional activity of Glis, promoting the transcription of Snail, Slug, and other EMT-related gene targets ([@ref96]; [@ref125]; [@ref40]; [@ref203]).

Novel studies have described the participation of Notch signaling, an original paracrine pathway, in angiogenesis, tumor progression, cell proliferation, and EMT induction. The initiation of Notch relies on the trans-interactions between Notch ligands (Jag1, Jag2, Delta1, Delta3, and Delta4) at cell surface of signaling-sending cells and extracellular domains of noncovalent heterodimeric transmembrane Notch receptors (Notch1, Notch2, Notch3, and Notch4) on the surface of signaling-receiving cells. An initial cleavage at the extracellular site of the notch receptor mediated by a disintegrin and metalloproteinase (ADAM) follows the activation of Notch receptor ([@ref115]; [@ref13]). After the second intracellular cleavage mediated by γ-secretase, Notch intracellular domain (NICD) with activated transcriptional activity is released and then translocates into the nucleus, mediating the transcriptional upregulation of hairy and enhancer of split (HES) family genes and the HES related with YRPW motif (HEY) family genes in cooperation with co-regulators. These effectors further induce the corresponding downstream transcriptional modification, such as the induction of Snail and Slug ([@ref163]; [@ref172]; [@ref95]).

A specific consequence of the multiple signal transduction networks reviewed above is the increase of cell motility. To drive the process of migration and invasion, the subtle remodeling of cytoskeleton dynamics accompanied by the tuning of epithelial adhesion, which is directly regulated by focal adhesion kinase (FAK), Rho family GTPase, and Rho-associated protein kinase (ROCK) signaling, is highly activated, leading to actin polymerization, stress fiber assembly, lamellipodia and filopodia formation, and the creeping-like motions of the cells ([@ref9]; [@ref197]; [@ref73]; [@ref70]). A schematic overview of the pro-EMT pathways and key messengers is shown in [Figure 1](#fig1){ref-type="fig"}.

![Brief schema of the putative signaling transduction mechanisms underlying EMT. Activation of the Wnt/β-catenin, PI3K/Akt, Ras/ERK, TGF-β/SMAD2/3, BMP/SMAD1/5/8, JAK/STAT3, Shh, and Notch pathways is highly correlated with EMT. After ligand-receptor binding, intracellular secondary messengers are activated and initiated downstream transduction, which generally induce the nuclear translocation of signaling-specific TFs and the transcriptional regulation of EMT-related genes, such as CDH1 and CDH2, EMT TFs, and mesenchymal markers, accompanied by a series of alterations on cellular physiological or pathological activities (e.g., disjunction of adherin junctions, cytoskeleton remodeling, and increase of cellular motility). Arrows represent the molecular interactions in which downstream messengers are activated; T shape arrows represent inhibitive molecular interactions. EMT, epithelial-mesenchymal transition; PI3K, phosphoinositide 3-kinase; ERK, extracellular signal-regulated protein kinase; TGF-β, transforming growth factor β; JAK, Janus kinase; Shh, sonic hedgehog; TFs, transcription factors.](fphys-10-01404-g001){#fig1}

Potential Mechanisms of PM~2.5~-Induced Epithelial-Mesenchymal Transition {#sec5}
=========================================================================

Potential Reactive Oxygen Species-Dependent Mechanisms in PM~2.5~-Induced Epithelial-Mesenchymal Transition {#sec6}
-----------------------------------------------------------------------------------------------------------

ROS are physiologically produced as byproducts of biological reactions in the cytoplasm, mitochondria, and peroxisomes catalyzed by cytochrome P450 and NADPH oxidase (NOX). ROS have primary functions to actively defend against invading pathogens ([@ref3]; [@ref90]). However, excessive cytoplasmic retention of ROS generally results in cellular oxidative stress, which can alter intracellular signaling, DNA damage, and apoptosis ([@ref24]; [@ref28]; [@ref170]; [@ref17]). Intracellular ROS can be generated by cellular exposure to external contaminants, including the main components of PM~2.5~, such as black carbon, redox-active metals (e.g., Fe, Cu, Ni, Zn, Cr, As, and Mn), and PAHs (e.g., naphthalene, benzo-*a*-pyrene, and anthracene) ([@ref149]; [@ref121]; [@ref157]). PM~2.5~ particles have also been characterized as strong inducers of ROS, as they directly release ROS, catalyze redox reactions, or participate in redox cycles as substrates ([@ref152]; [@ref81]; [@ref132]; [@ref168]; [@ref17]; [@ref74]).

As ROS has been well characterized as one of the fundamental intermediaries of the PM~2.5~-induced response and injury, and evidence verifying PM~2.5~-induced EMT *via* ROS *in vivo* and *in vitro* has been emerging, this section will be mainly focused on the potential pathogenic role of PM~2.5~-derived ROS in EMT ([@ref162]; [@ref190]; [@ref196]; [@ref126]; [@ref102]). Some essential information including the sources and the concentrations of PM~2.5~ utilized, as well as the antioxidant used for treatment and the effective concentrations, is summarized in [Table 2](#tab2){ref-type="table"}.

###### 

Summary table about exposure assays of some studies reviewed in section "Potential Reactive Oxygen Species-Dependent Mechanisms in PM~2.5~-Induced Epithelial-Mesenchymal Transition."

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Source of PM~2.5~                                                                                      Dose of PM~2.5~ exposure   Duration of exposure        Cell type                                                   Antioxidant                 Dose of antioxidant   Reference
  ------------------------------------------------------------------------------------------------------ -------------------------- --------------------------- ----------------------------------------------------------- --------------------------- --------------------- -----------
  Collected at Atlanta, USA, from March 1, 2004 to June 30, 2004 using Teflon filter                     0.1, 1, 10 μg/cm^2^        5 days                      Rat alveolar type II epithelial cell line (RLE-6TN cells)   *N*-Acetyl cysteine (NAC)   5 μmol/L              [@ref34]

  Collected at Beijing, China, from January 19, 2015 to January 21, 2015 using 90-mm Emfab filter        1, 5, 30 μg/cm^2^          Single exposure: 1 day\     Human bronchial epithelial cell line (BEAS-2B cells)        NAC                         100 μmol/L            [@ref166]
                                                                                                                                    Repeated exposure: 7 days                                                                                                                 

  Collected at Changchun, China, from November 2015 to March 2016 using quartz filter                    25 μg/cm^2^                1, 6, 12, 24 h              Human bronchial epithelial cell line (BEAS-2B cells)        NAC                         5 μmol/L              [@ref151]

  Ni ions were bought from Sigma, USA                                                                    Ni^2+^: 0.4 μmol/L         24 h                        Human lung cancer cell line (A549 cells)\                   NAC                         5 mmol/L              [@ref192]
                                                                                                                                                                Human lung fibroblast cell line (MRC-5 cells)                                                                 

  Collected at Guangzhou, China, using quartz filter                                                     20, 50, 100 μg/ml          24 h                        Human corneal epithelial cell line (HCEC cells)             NAC                         1 mg/ml               [@ref22]

  Bought from National Institute of Standards and Technology (NIST), USA (the product label: SRM 2786)   2.5, 5, 10 μg/ml           24 h                        Human hepatic stellate cell line (LX-2 cells)\              NAC                         1 mmol/L              [@ref129]
                                                                                                                                                                Human primary hepatic stellate cells (HSCs)                                                                   

  Collected at Beijing, China, from January 2009 to June 2009 using nitrocellulose filter                8, 16, 32, 64 μg/cm^2^     12, 24, 48 h                Human lung cancer cell line (A549 cells)                    NAC                         5 mmol/L              [@ref27]
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

### PM~2.5~-Reactive Oxygen Species Participates in SMAD-Dependent Epithelial-Mesenchymal Transition {#sec7}

TGF-β has been shown to involve ROS formation *via* NOX4, whereas ROS also stimulate the epithelial excretion of TGF-β ([@ref88]). ROS can also convert latent TGF-β to its active form by oxidizing the latency-associated peptide (LAP) ([@ref104]; [@ref119]; [@ref69]). Excessive ROS derived from protein oxidation can induce TβRI/II expression and further initiate TGF-β/SMAD signaling, which induces EMT in hepatocytes *in vivo* and *in vitro* ([@ref158]). These studies indicate that ROS can activate TGF-β/SMAD signaling at different points along the pathway, including ligand-receptor interactions and intracellular signaling.

An *in vivo* study demonstrated that long-term PM~2.5~ exposure induced increased TGF-β1 expression, SMAD2/3 phosphorylation, and collagen accumulation in mice lungs, indicating potential links among PM~2.5~ exposure, the TGF-β1/SMAD2/3 pathway, and pro-fibrotic EMT ([@ref50]). Another study supported this pathogenesis in mice model: Maternal exposure to PM~2.5~ could also result in significant oxidative stress, activation of TGF-β/SMAD3 signaling, and EMT in fetal mice lung, which contributed to postnatal pulmonary dysfunction ([@ref159]). In addition, exposure of mice to PM~2.5~ for 4 weeks not only elicited SMAD3 phosphorylation and cardiac fibrosis but also induced excessive ROS accumulation and NOX4 expression in heart tissues, indicating that the potential occurrence of PM~2.5~-induced EMT or endothelial-mesenchymal transition (EndMT) might be ROS dependent ([@ref128]). Our previous *in vitro* study validated this mechanism: The release of TGF-β1, the activation of the TGF-β1/SMAD3 pathway, and the altered expression of hallmark EMT proteins in human bronchial epithelial cells were observed after 30-passage low-dose PM~2.5~ exposure ([@ref185]). In another study, the exposure of alveolar epithelial cells to PM~2.5~ not only induced the activation of latent TGF-β but also increased cell contractility and elongated cellular morphology in a dose-dependent manner. These effects could be reversed by NAC treatment, demonstrating the role of ROS in this pathogenic event ([@ref34]). In addition, increased TGF-β1 mRNA expression was observed in bronchial epithelial cells after 7 days' consecutive exposure to PM~2.5~, and treatment with the antioxidant NAC could also effectively offset the toxicity of PM~2.5~ exposure ([@ref166]). However, the detailed EMT transcription patterns induced by PM~2.5~-induced ROS through the SMAD2/3-dependent pathway remain unknown.

In summary, these data demonstrate that PM~2.5~ might induce EMT *via* ROS in a TGF-β/SMAD2/3 signaling-dependent manner. However, additional research is needed to further establish a firm causal link.

### PM~2.5~-Reactive Oxygen Species Might Induce Epithelial-Mesenchymal Transition *via* NF-κB Cascades {#sec8}

The activation of NF-κB can be evoked by ROS. NF-κB is activated as the response of cellular oxidative stress, responsible for inflammation, apoptosis, and differentiation. Moreover, the activation of NF-κB by ROS is also correlated with Snail upregulation and EMT phenotype transformation in epithelial cells ([@ref168]; [@ref20]). Different antioxidant treatments targeting ROS in human non-small cell lung carcinoma cells, pancreatic cancer cells, and hepatocellular carcinomatous cells all effectively inhibit NF-κB activation, which further represses matrix metalloproteinase (MMP) expression together with cellular migration and invasion ([@ref91]; [@ref12]; [@ref62]). In addition, IL-6 and IL-8, which are transcriptionally upregulated by ROS-activated NF-κB, also exert pro-EMT abilities *via* downstream JAK/STAT3 signaling ([@ref56]). In gastric cancer cells, even the regulatory effects of IL-6/JAK/STAT3 on expression of pro-EMT TFs and EMT markers relied on NOX4, indicating the potential comprehensive role of ROS in the transduction of NF-κB/IL-6 signaling ([@ref43]). NF-κB is also able to induce TNF-α expression in response to ROS stimulation, and activated TNF-α receptors in turn upregulate NF-κB transcription with further Snail expression, implying positive feedback loops underlying ROS-induced EMT *via* NF-κB ([@ref32]).

A novel publication confirmed the positive role of NF-κB in PM~2.5~-induced EMT. Organic extracts of PM~2.5~ enhanced the binding of NF-κB with the promoter of long non-coding RNA (lncRNA) MALAT1, and MALAT1 relieved the expression silencing of ZEB1 by sponging miR-204 targeting ZEB1 mRNA, resulting in the mesenchymal phenotype transition of pulmonary epithelial cells ([@ref109]). Another novel study showed the correlation between PM2.5, ROS, NF-κB, and pro-fibrotic EMT in vivo. The oxidative stress within the rat lungs exacerbated during PM2.5 exposure but disappeared after the termination of exposure, and the upregulation of RelA/p65, deteriorated pulmonary fibrosis, and EMT in rat lungs were observed in the post-exposure phase, indicating that PM2.5 might lead to pulmonary fibrosis by oxidative stress-initiated NF-κB/inflammation/EMT pathway ([@ref520]). Moreover, a previous study demonstrated that NF-κB activation following PM~2.5~ exposure can be ROS dependent: The inhibition of ROS effectively abrogated the sustained NF-κB activation in BEAS-2B bronchial epithelial cells induced by PM~2.5~ exposure ([@ref151]). Mice exposed to ultrafine carbon black particles showed oxidant-dependent NF-κB activation and increased expression of NF-κB responsive genes including TNF-α and IL-6 in lung tissues ([@ref148]). Silica particles, a kind of well-described pro-fibrotic agent, were able to induce a similar pathological response in silicosis murine models, whereas non-fibrogenic particles failed to induce this effect. These results implied that ROS-derived NF-κB and its downstream inflammatory mediators actively participate in fibrogenesis, in which EMT might act as a major participant ([@ref64]). Additionally, an *in vitro* study showed increased IL-6 level and downstream JAK2/STAT3 signaling activation concomitant with the emergence of oxidative stress in PM~2.5~-treated alveolar cancer cells, whereas a similar pattern was also observed in another *in vitro* study, in which ROS accumulation, IL-6/IL-8 release, and JAK2/STAT3 signaling pathway activation were observed to be mediated by cytochrome P450, family 1, member A1/B1 (CYP1A1/B1) after PM~2.5~ exposure to human bronchial epithelial cells ([@ref198]). This evidence partly substantiated the hypothesis that PM~2.5~ might induce EMT *via* ROS/NF-κB/IL-6/8/JAK/STAT3 axis ([@ref187]). Although the NF-κB activation and following release of IL-6, IL-8, TNF-α, or mitochondrial dysfunction in epithelial tissues induced by PM~2.5~-derived ROS have been validated to be significant in lung inflammation and cell death, the in-depth regulatory role of this shared pathway in EMT is largely unknown ([@ref6]; [@ref89]; [@ref105]; [@ref177]; [@ref183]). Currently, the link between cigarette smoke extract (CSE) and pulmonary inflammation together with EMT in airway epithelia has been preliminarily verified. CSE-induced inflammatory responses in human bronchial cells include NF-κB activation and further increased IL-6 transcription, which promote phenotype transformation *via* downregulation of miR-200-c, a proven anti-EMT micro-RNA (miRNA) family member. Hence, ROS in conjunction with NF-κB might lie at the intersection of PM~2.5~-derived inflammation and EMT, although the exact mechanisms remain to be elucidated ([@ref206]). Controversy on this issue also existed. Fe~3~O~4~, one of the major anthropogenic components in PM, could result in a delayed NF-κB response in A549 neoplastic pulmonary epithelial cells as a result of the decrease in IκB degradation induced by excessive ROS ([@ref83]).

In summary, whether PM~2.5~-intracellular ROS induced NF-κB phosphorylation could initiate EMT is still obscure, as the small amount of peripheral proof is too weak to conclusively establish this stand.

### PM~2.5~, Reactive Oxygen Species, and Receptor Tyrosine Kinase Signaling {#sec9}

ROS are strong initiators of pro-EMT PI3K/Akt and Ras/ERK signaling. ROS have been shown to directly induce the phosphorylation of EGF and PDGF receptors in the absence of ligand and to enhance VEGF-induced receptor phosphorylation *via* oxidative repression of the intracellular inhibitors protein tyrosine phosphatase-1B (PTP1B) and density-enhanced phosphatase-1 (DEP1) ([@ref92]; [@ref124]; [@ref94]). The ROS-induced conversion of PIP~2~ to PIP~3~ also initiates Akt signaling events ([@ref204]). Additionally, glutathione peroxidase inactivation-induced ROS accumulation resulted in the acquisition of mesenchymal characteristics of pancreatic cancer cells by the Akt/GSK-3β/Snail regulation ([@ref114]). Likewise, the inhibition of GSK-3β, which increases Snail transcriptional activity and an EMT-like phenotype following ROS-stimulated ERK activation instead of Akt, was observed in *Helicobacter pylori*-treated gastric cancer cells ([@ref120]). Besides, the definitive role of ROS in activating ERK to promote the invasion of vascular smooth muscle cells and keratinocytes has also been unfolded. ROS-mediated ERK phosphorylation is also a significant alternative pathway for TGF-β-induced EMT in renal tubular epithelial cells ([@ref131]; [@ref181]).

PM~2.5~ has been extensively regarded to stimulate the ERK or Akt pathway. PM~2.5~ could induce MMP-13 expression, invasion, and migration of hepatocellular carcinoma cells *via* Akt ([@ref202]). The increased secretion of EGF by human alveolar epithelial cells after PM~2.5~ exposure and the further initiation of intracellular EGFR/ERK/NF-κB have also been observed ([@ref72]). In addition, a microfluidic system-based study on PM~2.5~-treated bronchial epithelial cells showed significant activation of PI3K/Akt pathway, FGF/FGFR/MAPK/VEGF signaling, and the JAK/STAT pathway, which led to cell proliferation and apoptosis evasion. And increased intracellular and mitochondrial ROS levels implicated that PM~2.5~-derived ROS could be correlated with the activation of these signaling series ([@ref207]).

In addition to ERK, other members of the MAPK family have been shown to participate in PM~2.5~ responses. The coordination of p38 MAPK with proliferating cell nuclear antigen (PCNA) was responsible for PM~2.5~-induced vascular smooth muscle cell proliferation, and the positive role of ROS was also implied by upregulation of superoxide dismutase (SOD), a cellular oxidative stress biomarker ([@ref173]). Nevertheless, current research on the toxicology of PM~2.5~-ROS also primarily focuses on the linkage between Akt or MAPK activation and inflammation or apoptosis, suggesting a double-edged role of PM~2.5~-ROS that could either induce cell death or enhance cell viability ([@ref2]; [@ref101]). Abundant in PM~2.5~, Ni^2+^ was shown to be responsible for cellular oxidative stress and the phenotype transformation of alveolar epithelial cells, and ROS/Akt-dependent MMP-9 and COL1 induction. Similarly, Ni^2+^/ROS/Akt also led to the inflammation of pulmonary epithelia and mice lung tissues ([@ref192]). Hence, there is also crosstalk between PM~2.5~-ROS-induced inflammation and EMT *via* RTK-related cascades. However, further research is needed to clarify the interplay of PM~2.5~, ROS, Akt, and ERK with EMT.

### PM~2.5~-Derived Reactive Oxygen Species: The Double-Edged Sword on Cytoskeleton Remodeling {#sec10}

Increase of cell invasion/migration is the characteristic of EMT regulated by subtle cytoskeleton remodeling and shifting in adhesion. TGF-β-induced intracellular ROS *via* NOX4 accelerates the polymerization of globular actin (G-actin) to fibrous actin (F-actin) in human umbilical vein endothelial cells, which is essential for lamellipodia and filopodia formation ([@ref59]; [@ref87]). ROS generated by NOX1 was also able to induce the spindle-like cellular morphology, EMT, and differentiation of human gingival epithelial cells *via* the post-transcriptional accumulation of CK18, a kind of pro-EMT intermediate filament ([@ref141]). And ROS/ErbB2 signaling was also reported to be responsible for the aggressiveness of breast epithelial cells by phosphorylating FAK and activating RhoC ([@ref176]). In another study, although mere H~2~O~2~ treatment was not sufficient to induce complete EMT in retinal pigment epithelial cells due to the transiency of the stimulation, ROS could also initiate Rho-GTP binding, resulting in stress fiber formation ([@ref67]).

PM~2.5~ has been verified as the modulator of cytoskeleton inducing incomplete contact between adjacent human bronchial epithelial cells, in which strong oxidative stress was also observed ([@ref107]). Besides, long-term chronic PM~2.5~ exposure to human bronchial epithelial cells could enhance RhoA-GTP binding and stress fiber formation, although no increase of cellular proliferation was observed ([@ref33]). In another research, however, PM~2.5~ that stimulated ROS generation in corneal epithelial cells failed to promote EMT *via* cytoskeletal regulation. On the contrary, PM~2.5~ inhibited FAK and paxillin phosphorylation, which further repressed RhoA activity and epithelial cell migration. Now that these inhibitory processes could be reversed with NAC treatment, the discrepant roles of PM~2.5~-derived ROS in cytoskeleton regulation have been identified ([@ref22]). In summary, the lack of comprehensive data leaves the role of PM~2.5~ in cytoskeleton modulation shadowy.

### Something New: PM~2.5~-Reactive Oxygen Species-Induced Autophagy Participates in Epithelial-Mesenchymal Transition {#sec11}

Autophagy is a cellular degradation process that is activated in response to environmental stressors such as GF depletion and hypoxia ([@ref194]; [@ref111]). Recent evidence has linked autophagy and EMT through shared signaling pathways and functional causality in cancer progression and metastasis ([@ref110]; [@ref100]; [@ref8]; [@ref54]; [@ref200]). A recent study verified that PM~2.5~ participated in liver fibrosis *via* ROS-mediated mitophagy. Hepatic stellate cells, a principal liver cell type with EMT plasticity, displayed enhanced α-SMA and COL1 expression after PM~2.5~ treatment. These processes were mediated by ROS-induced PTEN-induced kinase 1 (PINK1) and Parkin, which signified mitophagy ([@ref19]; [@ref129]). In lung cancer cells, PM~2.5~-induced cell migration and invasion depended on autophagy, which was initially induced by increased intracellular ROS and its downstream effector lncRNA, loc146880 ([@ref27]). Another study revealed an alternative mechanism underlying PM~2.5~-autophagy-EMT in lung cancer cells, in which upregulated lncRNA LCPAT1 served as a messenger that mediated autophagy and cell migration by interacting with RCC2 after PM~2.5~ exposure ([@ref103]). This evidence not only validates the correlation between autophagy and PM~2.5~-induced epithelia phenotype transformation but also provides new insight into the epigenetic toxicology of PM~2.5~.

Other Molecular Events Underlying PM~2.5~-Induced Epithelial-Mesenchymal Transition {#sec12}
-----------------------------------------------------------------------------------

Information about exposure assays in this section is selectively summarized in [Table 3](#tab3){ref-type="table"}.

###### 

Summary table about exposure assays of some studies reviewed in section "Other Molecular Events Underlying PM~2.5~-Induced Epithelial-Mesenchymal Transition."

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Source of PM~2.5~ for treatment                                                             Dose of PM~2.5~ exposure              Duration of exposure                                                             Cell type                                              Reference
  ------------------------------------------------------------------------------------------- ------------------------------------- -------------------------------------------------------------------------------- ------------------------------------------------------ ---------------
  ***In vitro* assays**                                                                                                                                                                                                                                                     

  Collected at Beijing, China, from December 2016 to February 2017 using glass fiber filter   25, 50, 100 μg/ml                     Chronic exposure for 5 passages                                                  Human lung cancer cell line (A549 cells)\              [@ref179]
                                                                                                                                                                                                                     Human bronchial epithelial cell line (BEAS-2B cells)   

  Collected at Shenyang, China, in winter using nitrocellulose filter                         5, 10, 20 μg/cm^2^                    72 h                                                                             Human lung cancer cell line (A549 cells)\              [@ref193]
                                                                                                                                                                                                                     Human lung cancer cell line (H292 cells)               

  Collected at Shanghai, China, from November 2017 to June 2018 using glass fiber filter      50 μg/mL                              Chronic exposure for 30 passages                                                 Human bronchial epithelial cell line (BEAS-2B cells)   [@ref186]

  Bought from NIST, USA (the product label: SRM 1648a)                                        100, 500 μg/ml                        Chronic exposure for 30 passages                                                 Human bronchial epithelial cell line (HBE cells)       [@ref42]

  Collected at Nanjing and Shanghai, China, in Autumn 2014 using quartz filter                Organic extract of PM~2.5~: 5 μg/ml   48 h                                                                             Human lung cancer cell line (A549 cells)\              [@ref61]
                                                                                                                                                                                                                     Human bronchial epithelial cell line (BEAS-2B cells)   

  Obtained from a biomass power plant                                                         100 μg/ml                             5 weeks                                                                          Human bronchial epithelial cell line (BEAS-2B cells)   [@ref57]

  Collected at Shanghai, China in four seasons using glass fiber filter                       20, 40, 60, 80, 100 μg/ml             24 h                                                                             Human bronchial epithelial cell line (BEAS-2B cells)   [@ref207]

  **Source of PM~2.5~ for treatment**                                                         **Dose of PM~2.5~ exposure**          **Method and duration of exposure**                                              **Animal**                                             **Reference**

  ***In vivo* assays**                                                                                                                                                                                                                                                      

  Collected at Beijing, China, from December 2016 to February 2017 using glass fiber filter   2.5, 10, 20 mg/kg\                    Intratracheal instillation\                                                      8-week-old male BALB/c mice                            ([@ref179])
                                                                                              Diluted in saline                     Once/3 days, lasted for 90 days                                                                                                         

  Bought from NIST, USA (the product label: SRM 1648a)                                        0.4 mg/m^3^                           Dynamic inhalation exposure using the exposure chambers and aerosol generator\   8-week-old C57BL/6 mice                                ([@ref42])
                                                                                                                                    Lasted for 21 days                                                                                                                      
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

### Participation of Novel Signaling and Molecules in PM~2.5~-Induced Epithelial-Mesenchymal Transition {#sec13}

PM~2.5~ can also activate EMT *via* diverse signaling pathways, including HMGB1-receptor for advanced glycation end-products (RAGE), Shh, Wnt/β-catenin, and Notch pathway together with SMAD1 signaling, in which the role of ROS has not been elucidated. HMGB1 and its cognate receptor RAGE were both induced in human bronchial epithelial cells and in the murine airway in response to PM~2.5~ exposure. HMGB1 binding further activated TGF-β1 and PDGF release, providing strong evidence that HMGB1 is a mediator of PM~2.5~-induced EMT ([@ref209]). Increased Shh expression activated downstream Shh/Gli1 signal transduction and further enhanced Snail expression as well as cell migration after low dose PM~2.5~ exposure to human bronchial smooth muscle cells ([@ref195]). Moreover, the enhanced expression of Notch1 together with downstream TFs Hes1, Snail, Slug and biomarkers of EMT was detected in lungs of mice after intratracheal instillation of PM~2.5~ with varied concentrations. The induction of cancer stem cells markers including OCT4 and SOX2 in A549 neoplastic pulmonary epithelial cells following the activation of PM~2.5~/Notch1 pathway further validated the pro-EMT property of PM~2.5~ ([@ref179]). Furthermore, unlike the SMADs-dependent EMT mechanisms stated above, SMAD1 activity could also be indirectly induced by repressing expression of SMAD6/7 after PM~2.5~ treatment on neoplastic pulmonary epithelial cells, resulting in the inhibition of SMAD1 degradation and induction of the spindle-like cellular morphology with cadherin switch ([@ref193]). Interestingly, rather than directly responding to PM~2.5~ exposure, Wnt/β-catenin signaling promoted the proliferation of human alveolar cancer cells and xenograft tumor growth *via* PM~2.5~-induced Wnt3a-enriched exosomes ([@ref184]). Our recent research was focused on exosomal miRNAs of EMT-like pulmonary epithelia after PM~2.5~ exposure. It predicted the abnormal regulation of multiple cancer-related pathways by exosomal miRNAs in a systematic perspective, further emphasizing the significance of diverse interactions between exosomes and signaling pathways in the process of PM~2.5~-induced EMT ([@ref186]). ATP citrate lyase (ACLY) linking glycolytic and lipidic metabolism has been considered as a novel anticancer target, and recently, it has also been found responsible for PM~2.5~-induced EMT ([@ref49]). Increase of intracellular ACLY expression and citrate acid levels synchronized with EMT phenotype transformation of human bronchial epithelial cells after long-term PM~2.5~ exposure, and the knock down of ACLY significantly abrogated the *in vivo* metastasis ability of the cells ([@ref42]).

### Polyaromatic Hydrocarbons Might Function in PM~2.5~-Induced Epithelial-Mesenchymal Transition Through Aryl Hydrocarbon Receptor {#sec14}

Showing high affinity for a variety of PAHs, ligand-bound aryl hydrocarbon receptor (AHR) is able to interact with Ah receptor nuclear translocator protein (ARNT) and further mediate the toxicities of PAHs by stimulating the expression of target genes such as CYP1A1, which oxidizes PAHs and generally enhances their toxicities ([@ref134]; [@ref122]). The AHR-ARNT complex can also promote cell proliferation by binding to the Slug promoter, activating ERK in the absence of external GFs, and enhancing FGF, PDGFA, and PCNA production ([@ref146]; [@ref30]; [@ref130]; [@ref174]; [@ref134]; [@ref75]). Because PAHs account for a large portion of the organic constituents in PM~2.5~, their contribution to PM~2.5~-induced EMT might be nonnegligible. The significant *cyp1a1* upregulation following the exposure of HBE cells to diesel exhaust particles (DEPs) or the exposure of BEAS-2B and A549 cells to PM~2.5~ proved the ability of PM to activate AHR signaling ([@ref53], [@ref52]; [@ref133]). Likewise, inhibiting AHR or CYP1A1 in BEAS-2B and A549 epithelial cells before PM~2.5~ exposure could effectively rescue PM~2.5~-induced E-cadherin downregulation and N-cadherin upregulation. In this study, lncRNA MALAT1 showed synchronized expression tendency with N-cadherin, indicating that it functions as an effector regulating EMT at downstream of PM~2.5~/AHR signaling, in addition to its role in NF-κB pathway reviewed above ([@ref61]). These studies indicated that PM~2.5~/PAHs/AHR/CYP1A1 signaling significantly participates in EMT initiation, although more exploration is urgently needed.

### PM~2.5~ Induces Pro-Epithelial-Mesenchymal Transition Epigenetic Regulations {#sec15}

Epigenetic regulations through lncRNAs and miRNAs underlying PM~2.5~-induced EMT have been partly reviewed above. Besides that, miR-16-1-3p directly targeting Twist mRNA could be inhibited by PM~2.5~ exposure, participating in PM~2.5~ exposure-induced EMT of hepatocellular carcinoma cells ([@ref201]). Moreover, PM~2.5~ exposure also participates in initiation of EMT of bronchial epithelial cells by altering DNA methylation ([@ref97]). After 5 weeks of PM~2.5~ exposure, hypomethylated CpG islands (CpGs) in the genome of bronchial epithelial cells were significantly enriched in genes associated with GTPase activity, extracellular matrix organization, and GF stimuli, whereas hypermethylated CpGs were clustered in genes responsible for cell adhesion and ion transportation ([@ref57]). Another set of DNA methylation analyses on bronchial epithelial cells after PM~2.5~ exposure for 24 h showed comparable results, as Gene Ontology (GO) terms related with regulation on actin filament and adherin junction were significantly enriched in hypomethylated gene list ([@ref145]). Because these annotated genes play dominant roles in EMT, these *in silico* analyses strongly indicated an association between PM~2.5~ exposure and EMT from a systematic perspective.

### Calcium Might Act as an Initiator of Epithelial-Mesenchymal Transition in PM~2.5~? {#sec16}

Calcium signaling is highly correlated with multiple malignant cancers. Alterations in the expression of Ca^2+^ channels or transporters have been identified in tumor cells, indicating that ectopic Ca^2+^ signal transduction might play a role in EMT ([@ref23]). For example, the activation of transient receptor potential cation channel 7 (TRPM7) and Ca^2+^ influx through TRPM7 indicates the initiation of EMT. Furthermore, EGF-induced TRPM7-Ca^2+^-dependent STAT3 activation significantly upregulated Twist, Snail, and EMT marker expression in breast cancer cells ([@ref26]). Ca^2+^ is also able to elicit the expression of the ATP-binding cassette subfamily C member 3 (ABCC3), a promoter of Twist and EMT in breast cancer cells ([@ref153]). As Ca^2+^ has been well characterized as one of the most plentiful cations in PM~2.5~, and PM~2.5~ is able to penetrate into the bloodstream or be taken by cells, PM~2.5~ exposure might result in increased Ca^2+^ concentration in microenvironment around the epithelia or cytoplasm, which could further regulate the activity of pro-EMT Ca^2+^ signaling ([@ref63]; [@ref128]; [@ref182]). In our recent study, pulmonary epithelial cells showed EMT-like phenotype after long-term low dose PM2.5 exposure, and a subset of the intracellular differentially expressed genes was significantly related to the cellular response to calcium ion ([@ref186]). However, although limited *in vitro* studies have reported that PM~2.5~ exposure could raise the intracellular Ca^2+^ concentration of BEAS-2B cells and another non-epithelial cell line, the biological correlation of this event with EMT was yet to be clearly figured out ([@ref207]; [@ref205]).

Conclusions {#sec17}
===========

Accumulating evidence has shown that PM~2.5~ can exert its toxic effect on somatic cells resulting in disorders including carcinogenesis and fibrosis. As EMT endows the epithelia with the characteristics of mesenchymal cells, it has been recognized as one of the major pathogenic mechanisms that promote malignant tumor metastasis and fibrogenesis. We and other researchers have originally identified PM~2.5~ as an initiator of EMT. On the basis of studies investigating PM~2.5~ toxicology, in this review, we describe that PM~2.5~ might induce EMT by intermediary ROS, which induce the secretion of TGF-β, IL-6, IL-8, and TNF-α, as well as the activation of the SMADs, NF-κB, JAK/STAT3, ERK, Akt, and Rho GTPase-dependent cascades. However, only the role of PM~2.5~-derived ROS in EMT induction mediated by TGF-β/SMAD2/3 pathway has been relatively clearly uncovered, whereas other mechanisms are revealed by limited research. Because PM~2.5~-induced inflammation and apoptosis largely share collective key messengers with putative EMT molecular processes, the underlying subtle mechanisms that regulate these cellular events remain to be elucidated. In addition, preliminary evidence has shown a correlation between PM~2.5~-ROS-induced autophagy and EMT, although the interactions at the molecular level remain to be explored. Furthermore, PM~2.5~-induced EMT is also dependent upon HMGB1-RAGE, Shh, Wnt/β-catenin, Notch, SMAD1 signaling, and ACLY enzyme, in which the involvement of ROS remains unclear. It is worth mentioning that epigenetic regulations involving miRNAs, lncRNAs, and DNA methylation might act as transcriptional or posttranscriptional regulators in PM~2.5~-induced EMT. PAHs and Ca^2+^, the primary constituents of PM~2.5~, might specifically induce EMT by AHR and Ca^2+^ signaling, respectively [Figure 2](#fig2){ref-type="fig"}.

![Potential regulatory routes of PM~2.5~ in EMT. PM~2.5~ might function as an EMT initiator by activating TGF-β/SMAD2/3, NF-κB, ERK, Akt, and mediating cytoskeleton rearrangement *via* ROS. In addition to epigenetic mechanisms such as lncRNAs, miRNAs, and DNA methylation regulation, HMGB1-RAGE, Shh, SMAD1, Wnt3a/β-catenin, and Notch pathways have also been originally validated as effector signaling of PM~2.5~ in the process of EMT. ACLY might act as a key metabolic modulator in PM~2.5~-induced EMT. Autophagy following PM~2.5~-ROS can also promote EMT. Specific components within PM~2.5~ might be EMT promoters, as PAHs can initiate EMT *via* AHR/CYP1A1 signaling, and Ca^2+^ ions might function by activating Ca^2+^ signaling. EMT, epithelial-mesenchymal transition; TGF-β, transforming growth factor β; ERK, extracellular signal-regulated protein kinase; ROS, reactive oxygen species; RAGE, receptor for advanced glycation end-products; Shh, sonic hedgehog; ACLY, ATP citrate lyase; PAHs, polyaromatic hydrocarbons; AHR, aryl hydrocarbon receptor.](fphys-10-01404-g002){#fig2}

However, our present understanding of the toxicology of PM~2.5~ is still highly limited, as studies on PM~2.5~ toxicology are confined to a series of factors that might result in ineluctable systematic errors. It is clear that different sampling sites inevitably bring about variance of PM~2.5~ composition, as climate characteristics and social, economic, and cultural features are extremely diverse around the world. This natural diversity might make the results of different studies incomparable. Nevertheless, detailed studies investigating the toxicology of the exact components of PM~2.5~ could be difficult to perform. Second, although sampling protocols have been preliminarily standardized, inconsistencies between the actual operations of researchers uncontrollably exist, which might lead to a reduction in internal authenticity. Besides, the methods of PM~2.5~ treatment, including the selected vehicle solvent and the optimal concentrations to imitate the actual exposure state of humans, also significantly affect the physiology and pathological responses of cultured cells and murine models. According to existing studies, NAC is the widely used antioxidant against PM~2.5~ exposure, which shows strong efficacy of ROS elimination *in vitro*. However, the opposite effect of NAC on lung cancer cells, that is, growth promotion effect by reducing ROS, has been observed ([@ref142]). Besides, the failure of PANTHER combined therapy consisting of prednisone, azathioprine, and NAC designed for idiopathic pulmonary fibrosis also indicates that precise drug prevention is still far from mature ([@ref66]). Therefore, additional in-depth research and consensus are urgently needed. Owing to the relatively limited understanding of the underlying mechanisms of PM~2.5~-induced EMT, we comprehensively reviewed potential molecular events participating in PM~2.5~-induced EMT in various epithelial cell types that might be targeted by PM~2.5~ exposure. As tissue/cell type-specific responses to PM~2.5~ inevitably exist, the definitive role of PM~2.5~ in EMT should be further explored and confirmed.
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:   Epithelial mesenchymal transition
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:   Transcription factors
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:   Lymphoid enhancer-binding factor-1
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:   Transforming growth factor β
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:   Type I collagen
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:   Platelet-derived growth factor
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MEK
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:   Extracellular signal-regulated protein kinases
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:   Protein kinase B
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:   Signal transducers and activators of transcription-3

IL-6

:   Interleukin-6

IL-8

:   Interleukin-8

Shh

:   The sonic hedgehog

PTCH
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SMO

:   Smoothend
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:   Glima-associated oncogene-1/2/3

ADAM

:   A disintegrin and metalloproteinase
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:   Notch intracellular domain

HES

:   Hairy and enhancer of split family

HEY

:   The HES related with YRPW motif family

FAK

:   Focal adhesion kinase

ROCK

:   Rho-associated protein kinase

NOX

:   NADPH oxidase

LAP

:   Latency-associated peptide

EndMT

:   Endothelial-mesenchymal transition

NAC

:   *N*-acetyl cysteine

MMP

:   Matrix metalloproteinase

CYP1A1/B1

:   Cytochrome P450, family 1, member A1/B1

LncRNA

:   Long non-coding RNA

CSE

:   Cigarette smoke extract

MiRNA

:   Micro-RNA

PTP1B

:   Protein tyrosine phosphatase-1B
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:   Density-enhanced phosphatase-1

MAPK

:   Mitogen-activated protein kinase

PCNA

:   Proliferating cell nuclear antigen

SOD

:   Superoxide dismutase

F-actin

:   Fibrous actin
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:   Globular actin

PINK1

:   PTEN-induced kinase 1

RAGE

:   Receptor for advanced glycation end-products

ACLY

:   ATP citrate lyase
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:   Aryl hydrocarbon receptor
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:   Ah receptor nuclear translocator protein
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:   Gene Ontology
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ABCC3
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